Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

3,057 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Utility of preoperative liver biopsy in live-related donor patients for liver transplantation.
Monsour HP Jr, Wood RP, Ozaki C, Katz S, Clark J, Dyer C, Camel S. Monsour HP Jr, et al. Among authors: katz s. Transplant Proc. 1994 Feb;26(1):138-9. Transplant Proc. 1994. PMID: 8108910 No abstract available.
Pancreas transplantation utilizing thymoglobulin, sirolimus, and cyclosporine.
Knight RJ, Kerman RH, Zela S, Podbielski J, Podder H, Van Buren CT, Katz S, Kahan BD. Knight RJ, et al. Among authors: katz s. Transplantation. 2006 Apr 27;81(8):1101-5. doi: 10.1097/01.tp.0000203800.90554.07. Transplantation. 2006. PMID: 16641593
Thymoglobulin, sirolimus, and reduced-dose cyclosporine provides excellent rejection prophylaxis for pancreas transplantation.
Knight RJ, Kerman RH, Zela S, Podder H, Van Buren CT, Katz S, Kahan BD. Knight RJ, et al. Among authors: katz s. Transplantation. 2003 Apr 27;75(8):1301-6. doi: 10.1097/01.TP.0000061768.98058.EC. Transplantation. 2003. PMID: 12717220
The selective use of basiliximab versus thymoglobulin in combination with sirolimus for cadaveric renal transplant recipients at low risk versus high risk for delayed graft function.
Knight RJ, Kerman RH, Schoenberg L, Podder H, Van Buren CT, Katz S, Kahan BD. Knight RJ, et al. Among authors: katz s. Transplantation. 2004 Sep 27;78(6):904-10. doi: 10.1097/01.tp.0000134399.10352.e4. Transplantation. 2004. PMID: 15385812
Therapeutic drug monitoring of sirolimus for optimal renal transplant outcomes.
Kahan BD, Napoli KL, Podbielski J, Hussein I, Katz SH, Van Buren CT. Kahan BD, et al. Among authors: katz sh. Transplant Proc. 2001 Feb-Mar;33(1-2):1278. doi: 10.1016/s0041-1345(00)02476-3. Transplant Proc. 2001. PMID: 11267290 No abstract available.
A phase I study of a 4-week course of SDZ-RAD (RAD) quiescent cyclosporine-prednisone-treated renal transplant recipients.
Kahan BD, Wong RL, Carter C, Katz SH, Von Fellenberg J, Van Buren CT, Appel-Dingemanse S. Kahan BD, et al. Among authors: katz sh. Transplantation. 1999 Oct 27;68(8):1100-6. doi: 10.1097/00007890-199910270-00007. Transplantation. 1999. PMID: 10551636 Clinical Trial.
Therapeutic drug monitoring of sirolimus: correlations with efficacy and toxicity.
Kahan BD, Napoli KL, Kelly PA, Podbielski J, Hussein I, Urbauer DL, Katz SH, Van Buren CT. Kahan BD, et al. Among authors: katz sh. Clin Transplant. 2000 Apr;14(2):97-109. doi: 10.1034/j.1399-0012.2000.140201.x. Clin Transplant. 2000. PMID: 10770413
Stability of renal allograft glomerular filtration rate associated with long-term use of cyclosporine A.
Lewis R, Podbielski J, Sprayberry S, Munsell M, Katz S, Rubin M, Kimball P, Van Buren CT, Kerman R, Kahan B. Lewis R, et al. Among authors: katz s. Transplantation. 1993 May;55(5):1014-7. doi: 10.1097/00007890-199305000-00012. Transplantation. 1993. PMID: 8497874 Clinical Trial.
Microgravity culture conditions decrease immunogenicity but maintain excellent morphology of pancreatic islets.
Rutzky L, Kloc M, Bilinski S, Phan T, Zhang H, Stepkowski SM, Katz S. Rutzky L, et al. Among authors: katz s. Transplant Proc. 2001 Feb-Mar;33(1-2):388. doi: 10.1016/s0041-1345(00)02799-8. Transplant Proc. 2001. PMID: 11266875 No abstract available.
Sirolimus improves the two-year outcome of renal allografts in African-American patients.
Podder H, Podbielski J, Hussein I, Katz S, Van Buren C, Kahan BD. Podder H, et al. Among authors: katz s. Transpl Int. 2001 Jun;14(3):135-42. doi: 10.1007/s001470100315. Transpl Int. 2001. PMID: 11499902
3,057 results
Jump to page
Feedback